Navigation Links
By 2018, GlaxoSmithKline's Votrient Will Garner Sales of $640 Million and Will Overtake Pfizer's Sutent as the Renal Cell Carcinoma Market Leader
Date:9/14/2009

WALTHAM, Mass., Sept.14 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that, following its launch and uptake, GlaxoSmithKline's angiogenesis inhibitor Votrient (formerly Armala) will garner sales of $640 million by 2018 and will take significant market share away from Pfizer's Sutent. In 2008, Sutent had accounted for 61 percent of sales in the angiogenesis inhibitor drug class.

The new Pharmacor report entitled Renal Cell Carcinoma finds that Votrient will overtake Sutent as the renal cell carcinoma market leader by 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. For the treatment of renal cell carcinoma, Votrient is expected to launch in the U.S. in 2010, in Europe in 2011 and in Japan in 2012. According to the report, the angiogenesis inhibitor drug class will continue to dominate this market over the next decade, capturing 87 percent of total sales in 2018.

The report also finds that Novartis's Afinitor and Pfizer's axitinib will surpass Bayer Healthcare/Onyx's Nexavar and Wyeth's Torisel by 2018 in the second- and third-line treatment settings. In 2008, Nexavar was the leading therapy in the second-line setting and Torisel was the leading therapy in the third-line setting for the treatment of renal cell carcinoma.

"Thought leaders we interviewed indicate that they are optimistic about several emerging therapies, most notably axitinib and Votrient," said Decision Resources Analyst Karen Pomeranz, M.Sc., Ph.D. "One expert called axitinib 'the most exciting' emerging agent in renal cell carcinoma in recent years and another thought leader said that Votrient's clinical efficacy is comparable to that of Sutent and that Votrient has a more favorable side-effect profile than Sutent."

About Decision Resources

Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or

registered trademarks of their respective holders.

    For more information, contact:

    Decision Resources         Decision Resources, Inc.
    Christopher Comfort        Elizabeth Marshall
    781-296-2597               781-296-2563
    ccomfort@dresources.com    emarshall@dresources.com


'/>"/>
SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Masimo Rad-87(R) Pulse CO-Oximeter(TM) Garners Silver 2009 Medical Design Excellence Award
2. CyberKnife Center of Miami Executive Director James G. Schwade M.D. Garners Ultimate Miami CEO Award
3. AST Leaders Fly to Capitol Hill to Garner and Secure Support for Transplantation Initiatives
4. Tray-Pak Direct Mailer Garners 21% Response, Design Award
5. Absolutely PR's Maggie Holben Participates In CBSA BioBreakfast Expert Panel "How to Garner Media Attention & Effectively Use Public Relations Tactics"
6. Novel Anticoagulants Will Garner More Than Three-Quarters of the Atrial Fibrillation Drug Market in 2017
7. Novel IBS treatment developed at UB garners $8.5 million for seven-year clinical trial
8. Performance Health Technologies Garners Additional Media Coverage, Including Scientific Americans News Blog
9. Genentech/Roche/Chugais Avastin Will Garner More Than 20 Percent of the Total Breast Cancer Drug Market in 2017
10. Rising Garners Top Honors on the Private Company Indexs Top Five Growth Companies List for Q1 2008
11. Study garners unique mating photos of wild gorillas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... Forty-five percent of ... report that family members or friends have also commented about their poor hearing. ... wear hearing aids. One reason, suggested by 89 percent of American respondents, is ...
(Date:2/22/2017)... ... 22, 2017 , ... Pet obesity in the U.S. continued to steadily increase ... Association for Pet Obesity Prevention (APOP). During the ninth annual survey, APOP also found ... benefits of corn and grains, value of raw and organic diets, and the best ...
(Date:2/22/2017)... ... ... BrightStar Care Charleston , a home care and medical staffing agency, will ... on Aging’s Senior Expo on Thursday, March 23, 2017, at the Omar Convention ... our community. We are thrilled to participate in this event because we believe it ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... itself - the Vector™ Series Multi-Cook Oven offers up to four ovens in ... exclusive Structured Air Technology™ for unmatched evenness in cooking. Alto-Shaam has partnered with ...
(Date:2/21/2017)... MELBOURNE, Australia (PRWEB) , ... February 22, 2017 , ... ... believes it is valuable for every household and family to know all about it ... the publishing world with the release of “ Detox, Digestive and Wellness Solutions ” ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... 22, 2017 Research and Markets has ... by Drug Molecule (Biologic, Small Molecule Drugs), By Route of ... Blockers) Outlook 2022" report to their offering. ... The global psoriasis ... 2016-2022 This report provides a detailed analysis of ...
(Date:2/22/2017)... -- Based on its recent analysis of the sleep ... Inc. with the 2017 European New Product Innovation ... intelligently addresses the root causes of sleep apnea ... proven continuous transmucosal electrical stimulation therapy. Because of ... the most accessible anti-snoring products available in the ...
(Date:2/22/2017)... HAYWARD, Calif. , Feb. 22, 2017  Applied Silver, ... Sue Barnes to the company,s advisory board. Ms. Barnes ... total, joining business, advertising, engineering, legal, and healthcare experts ... , John Goodrich , J. Tress Ritter , ... RN, BSN, CIC, FAPIC brings more than three decades of ...
Breaking Medicine Technology: